Adenosine receptors: expression, function and regulation

S Sheth, R Brito, D Mukherjea, LP Rybak… - International journal of …, 2014 - mdpi.com
Adenosine receptors (ARs) comprise a group of G protein-coupled receptors (GPCR) which
mediate the physiological actions of adenosine. To date, four AR subtypes have been …

The A3 adenosine receptor: history and perspectives

PA Borea, K Varani, F Vincenzi, PG Baraldi… - Pharmacological …, 2015 - Elsevier
By general consensus, the omnipresent purine nucleoside adenosine is considered a major
regulator of local tissue function, especially when energy supply fails to meet cellular energy …

Purinergic signalling and cancer

G Burnstock, F Di Virgilio - Purinergic signalling, 2013 - Springer
Receptors for extracellular nucleotides are widely expressed by mammalian cells. They
mediate a large array of responses ranging from growth stimulation to apoptosis, from …

Cardiovascular adenosine receptors: expression, actions and interactions

JP Headrick, KJ Ashton, RB Rose'Meyer… - Pharmacology & …, 2013 - Elsevier
Intra-and extracellular adenosine levels rise in response to physiological stimuli and with
metabolic/energetic perturbations, inflammatory challenge and tissue injury. Extracellular …

Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis

RL Williams-Karnesky, US Sandau… - The Journal of …, 2013 - Am Soc Clin Investig
Epigenetic modifications, including changes in DNA methylation, lead to altered gene
expression and thus may underlie epileptogenesis via induction of permanent changes in …

A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy

KA Jacobson, S Merighi, K Varani… - Medicinal research …, 2018 - Wiley Online Library
The A3 adenosine receptor (A3AR) subtype is a novel, promising therapeutic target for
inflammatory diseases, such as rheumatoid arthritis (RA) and psoriasis, as well as liver …

Purinergic signalling in brain ischemia

F Pedata, I Dettori, E Coppi, A Melani, I Fusco… - …, 2016 - Elsevier
Ischemia is a multifactorial pathology characterized by different events evolving in the time.
After ischemia a primary damage due to the early massive increase of extracellular …

[HTML][HTML] Adenosine receptors and cancer

S Gessi, S Merighi, V Sacchetto, C Simioni… - Biochimica et Biophysica …, 2011 - Elsevier
Adenosine is a ubiquitous signaling molecule whose physiological functions are mediated
by its interaction with four G-protein-coupled receptor subtypes, termed A1, A2A, A2B and …

Pharmacological and therapeutic effects of A3 adenosine receptor agonists

P Fishman, S Bar-Yehuda, BT Liang, KA Jacobson - Drug discovery today, 2012 - Elsevier
The A3 adenosine receptor (A3AR) coupled to Gi (inhibitory regulative guanine nucleotide-
binding protein) mediates anti-inflammatory, anticancer and anti-ischemic protective effects …

The A3 adenosine receptor: an enigmatic player in cell biology

S Gessi, S Merighi, K Varani, E Leung… - Pharmacology & …, 2008 - Elsevier
Adenosine is a primordial signaling molecule present in every cell of the human body that
mediates its physiological functions by interacting with 4 subtypes of G-protein-coupled …